Tumor necrosis factor gene polymorphisms in ankylosing spondylitis

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• Ankylosing spondylitis (AS) is strongly associated with the HLA-B27 gene.
• Other genetic factors may contribute to AS pathophysiology.
• Tumor necrosis factor (TNF) genes, located near the HLA-B locus, are potential candidates for AS susceptibility.

Purpose of the Study:

• To investigate the role of tumor necrosis factor alpha (TNFalpha) and tumor necrosis factor beta (TNFbeta) gene polymorphisms in ankylosing spondylitis susceptibility.
• To determine if TNF gene variations confer an independent risk for AS beyond the HLA-B27 association.

Main Methods:

• Genotyping of TNFalpha (-308, -238) and TNFbeta promoter variations using PCR-RFLP.
• Analysis of 57 AS patients, 102 random controls, and 30 HLA-B*27-positive controls.
• Assessment of linkage disequilibrium between TNFbeta and HLA-B27 alleles.

Main Results:

• No significant differences in TNFalpha promoter polymorphisms (-308, -238) were observed between AS patients and controls.
• The TNFbeta genotype frequency was significantly different in AS patients compared to random controls.
• This TNFbeta genotype difference disappeared when comparing HLA-B*27-positive AS patients and controls, indicating linkage disequilibrium with HLA-B*27.

Conclusions:

• TNFalpha and TNFbeta gene polymorphisms do not appear to have an independent effect on ankylosing spondylitis susceptibility.
• The observed association of TNFbeta with AS is likely due to its strong linkage disequilibrium with the HLA-B27 allele.
• These findings suggest that other genetic factors, or environmental influences, may play a more significant role in AS pathogenesis beyond HLA-B27 and the studied TNF polymorphisms.